Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease
Part of paid clinical trials in New York, New York.
- Sponsor
- Xeno Holdings (US), LLC dba ChoironeX
- Study ID
- NCT07696962
- Phase
- PHASE1
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- End Stage Renal Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- ChoironeX GalKO Porcine Thymokidney — BIOLOGICALA constructed thymokidney from a genetically modified porcine donor will be preserved, packaged, transported and transplanted into the study subject at the study site in the same fashion as a human donor kidney. The thymokidney will remain in the subject throughout the subject's lifetime, or until thymokidney explant.
Study Details
The goal of this clinical trial is to learn if a GalKO Porcine Thymokidney can maintain renal function, without the need for dialysis, after transplantation into adult subjects with End Stage Renal Disease.
Key Dates
- First listed
- Jul 10, 2026
- Start date
- Jul 1, 2026
- Status verified
- Jul 2026
- Primary completion
- May 30, 2028
- Completion
- Sep 30, 2028
Study Design
- Enrollment
- 4 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Porcine ThymokidneyPorcine Thymokidney transplanted into patients with End Stage Renal Disease
Primary Outcome Measure
Incidence and severity of adverse events (AEs), serious adverse events (SAEs), and adverse events of special interest (AESIs) from Day 0 through Month 6. [ Time Frame: 6 months ]
Central Contacts
- Lindsey Dickerson+1 (347) 602-0721
- Gemma Hodgson
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Study Site 1 | New York | New York | 10032 | Research Coordinator |
| Study Site 2 | New York | New York | 10016 | Research Coordinator |
Find similar trials in New York, NY
By research site
Related Studies
- Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRDPHASE2 · Recruiting · Dicerna Pharmaceuticals, Inc., a Novo Nordisk company · San Francisco, California
- Safety and Efficacy of Empagliflozin in HemodialysisPHASE2 · Recruiting · NYU Langone Health · Boston, Massachusetts
- SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas StudyRecruiting · VenoStent · Bullhead City, Arizona
- Maturation of Arteriovenous Fistula With Automated Sonography Assessments TrialRecruiting · Sonavex, Inc. · Dothan, Alabama